Application Deadline: February 1, 2018
Clinical pharmacology is the science of developing and using drugs in the treatment of patients. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and methods in the real world. It has a broad scope, from the discovery of new target molecules to the effects of drug use in whole populations.
Clinical pharmacology connects the gap between medical practice and laboratory science. The clinical pharmacologist promotes the safety of prescriptions, maximizes the drug effects and minimizes the side effects. It is important that clinical pharmacologists interact with pharmacists who have special skill in the areas of drug information, medication safety and other aspects of pharmacy practice related to clinical pharmacology.
Clinical pharmacologists typically undergo rigorous medical and scientific training, which enables them to evaluate evidence and produce new data through well-designed studies. Clinical pharmacologists must have access to enough outpatients for clinical care, teaching and education, and research while under the supervision of medical specialists. Their responsibilities to patients include analyzing adverse drug effects, therapeutics, toxicology (including reproductive toxicology), cardiovascular risks, perioperative drug management, and psychopharmacology.
• To identify and support physician–scientists pursuing a career in clinical pharmacology.
• To encourage the development of junior research-oriented faculty who will use molecular, cell, and systems pharmacology to advance human research.
• To recruit promising individuals with a career commitment to study clinical pharmacology.
Eligibility & Requirements
• Applicants sponsored by medical schools should have at least two years of training at the residency level and two years of clinical experience in a research training program related to clinical pharmacology.
• Applicants should clearly wish to pursue a full-time career in clinical pharmacology. This is an important factor in the selection process.
• Facilities for research and training must be available to the applicant, and the program with which he or she is associated must have a demonstrated commitment to clinical pharmacology training, thus providing an environment where the applicant’s research potential can be developed to the fullest extent.
• Applicants must have a firm commitment from a U.S. university.
• All applicants must be U.S. citizens or permanent residents.
Award Description & Funding
• Awards are made to medical schools annually for two years to support full-time junior faculty in clinical pharmacology.
• Awards may be activated beginning July 1, 2018 or the first day of any month thereafter, up to and including December 1, 2018.
• The level of support is variable, but will not exceed $120,000 per year for salary and fringe benefits. The requested award must be within the range of prevailing salaries and fringe benefits in the primary department or unit in which the candidate will undertake his or her activities.
• A maximum of 8 percent of the award may be used for indirect institutional costs.
• The planned disposition of the requested award amount will be considered in the application’s review.
• The award will be made to the institution on behalf of the fellow. Funds are non-transferable. Any unused funds must be returned to the foundation.
Faculty Development Award in Clinical Pharmacology Application Checklist
Please make a copy of this list to reference during the application process, as incomplete applications will not be considered.
- General Registration Information
- Extended Letter which includes the following information:
- Personal data, education and training, experience in research and teaching, complete CV, chiefs of staff under whom candidate has served bibliography.
- Proposed faculty rank
- The school’s thoughts for support of the position following expiration of the award.
- Department of the school in which the candidate is or will be established and his affiliation with any other departments.
- While the program anticipates that the candidate may have teaching responsibilities, the program has as a primary focus the extension of the candidate’s research skills. Please list the distribution of time to be spent by the candidate in teaching, patient care and research. Include some appraisal of the impact of the time allotted for patient care commitments on the time allotted for research. It is expected that the awardee be guaranteed at least 50% protected time for research.
- List the amount of the candidate’s current and pending grant support, source and length of time grant will continue. If no support, please note this.
- This letter is an opportunity to tell us who you are and to describe your career and future plans. Include a synopsis of your career, your professional interests, and your desired career path. The letter should not exceed two single-spaced pages (12-point font).
- Research Plan-Please limit to 15 pages
- Complete and concise statement of the school’s plan for the activities of the candidate in the next two years, in relationship to the area of clinical pharmacology. The plan may include further research training either in the candidate’s own school or at another institution. The sponsoring institution should have a commitment to developing a program in clinical pharmacology and be able to demonstrate the ability to provide clinical pharmacology training in the future.
- Where the candidate will be involved in multiple research projects, indicate which projects will receive primary emphasis. Details on the proposed research must be provided to give information on the aims, methods and procedures to be used, significance of research, etc.
- If the candidate will have responsibilities in more than the sponsoring department during the award period, please include a letter from the chairman of each of these departments covering the candidate’s intended activities.
- Description of the facilities for research and training which will be made available to the candidate.
- A statement from the candidate on the extent of his commitment to clinical pharmacology and the role this program can have in his career development must be submitted.
- Applicants are requested to use a format similar to that specified for the submission of grants to the National Institutes of Health. This narrative should be limited to 15 pages. Acronyms should be put in a footnote on the first page or these should be spelled in full the first time they are used.
- The following letters are important consideration s in the review process:
- Letters of recommendation from the Dean of the medical school and the Chairman of the sponsoring department must be submitted online onto the application.
- Two additional letters of recommendation from those associated closely with the candidate during his scientific career should be submitted. These should not be from the candidate’s sponsor or chairman. These two letters should be submitted online and the original letter sent directly to the Foundation.
- The following letters are important consideration s in the review process:
Copies (PDF or Word doc.) or appropriate web link of each article published or ready for publication by the candidate which either have a direct bearing on the activities to be undertaken during the award, or are indicative of the candidate’s prior research accomplishments.
Letters and third-party materials should not be uploaded by the applicant. The application system will request contact information, including an email address, for your listed references. These individuals will receive a prompt from the application system with instructions for uploading their document(s), which will be appended to the application.
Based on our policy, we do not provide written reviews.
The 2018 Clinical Pharmacology brochure will be available later this year.